Sabby Management’s COSCIENS Biopharma CSCI Stock Holding History
Bought
Maintained
Sold
Other funds holding CSCI
Sabby Management's CSCI Position: Q3 2021 in Review
Sabby Management sold out of COSCIENS Biopharma (CSCI) in Q3 2021, closing a stake of 2,442 shares — an estimated $214K sold.
Sabby Management first reported a position in CSCI in Q4 2015 and held it in 11 quarters. The position peaked at $2.39M in Q4 2015. 31 funds tracked by Wall St. Rank hold CSCI as of Q3 2021.
- Sabby Management reported no remaining COSCIENS Biopharma position as of Q3 2021 after selling out during the quarter.
- Sabby Management sold 2,442 COSCIENS Biopharma shares in Q3 2021, an estimated $214K.
- Sabby Management first reported a position in COSCIENS Biopharma in Q4 2015 and held it in 11 quarters.
- Sabby Management's COSCIENS Biopharma position peaked at $2.39M in Q4 2015.
- 31 funds tracked by Wall St. Rank held COSCIENS Biopharma as of Q3 2021.
Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.